Study on Bone Metabolic Mechanism and Clinical Application of Qianggu Yin in the treatment of Primary Type I Osteoporosis

Phase 1

Recruiting

• Conditions: Primary type I osteoporosis

• Registration Number: ITMCTR2000004058
• Lead Sponsor: The Second Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

According to the diagnostic criteria of osteoporosis; postmenopausal women; 55-65 years old.

Exclusion Criteria

1.Diabetes mellitus, Cushing syndrome, changes in thyroid or parathyroid function, osteomalacia, rheumatoid arthritis, multiple myeloma, bone tumor, osteoarthropathy, Paget's disease, osteogenesis imperfecta and other diseases that seriously affect bone or calcium metabolism;
2.has taken estrogen, steroid hormone, calcitonin, parathyroid hormone, and both in the past 6 months Phosphate, fluoride, vitamin D, anticonvulsants, diuretics and other drugs that affect bone metabolism;
3.combined with cardiovascular, cerebrovascular, hematopoietic system and other serious primary type I disease; combined with severe liver and kidney dysfunction; mental illness or Alzheimer's disease.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bone density;

Secondary Outcome Measures

Name	Time	Method
Detection of bone turnover markers;